News
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...
Alibaba has introduced its newest product, Wan2.1 VACE, a state-of-the-art visual generation platform from Tongyi Lab. This ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Why is an increase of nearly 48% in India’s coastline relevant to the UPSC exam? What is the significance of topics such as ...
A new study has shown that the physical structure of food affects the hormones released as part of digestion. This means that ...
A new study from Imperial has shown that the physical structure of food influences the hormones released as part of digestion ...
A new study from Imperial has shown that the physical structure of food influences the hormones released as part of digestion.These hormones ...
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results